Bookmark and Share
AGN-PC-09QAV1 (CID 53308661) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(5)
 
 
Inactive(4)
 
 
Top Targets:
PTZ00371(3)
 
 
 
M1 APN 1(1)
 
 
Peptidase M17(1)
 
 
BioAssay Types:
Confirmatory(6)
 
 
 
BioActivity Types:
IC50(5)
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 7    Data Row: 9   Total Pages: 1   
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID124767876]
IC50 2.2Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (M18AAP): radiolabel-based cell-based dose response assay to identify compounds that inhibit P. falciparum growth in RBCs, Set 2. [AID743024, Type: confirmatory]
View
2
[SID124767876]
Average CC50 21.83Vero Cytoxicity Assay: A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) [AID588714, Type: confirmatory]
View
3
[SID124767876]
Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (M18AAP): radiolabel-based cell-based assay to identify compounds that inhibit P. falciparum growth in RBCs, Set2 [AID720736, Type: other]
View
4
[SID124767876]
Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (M18AAP): radiolabel-based cell-based assay to identify compounds that inhibit P. falciparum growth in RBCs, Set2 [AID720736_1, Type: other]M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124507185]
View
5
[SID124767876]
Late stage assay provider results from the probe development effort to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (M18AAP): radiolabel-based cell-based assay to identify compounds that inhibit P. falciparum growth in RBCs, Set2 [AID720736_2, Type: other]M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124507185]
View
6
[SID124767876]
Average hM18AAP IC50 Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the human M18 Aspartyl Aminopeptidase (hM18AAP) [AID588696, Type: confirmatory]Chain A, Crystal Structure Of Human Aspartyl Aminopeptidase (Dnpep), In Complex With Aspartic Acid Hydroxamate [gi:291191219]
View
7
[SID124767876]
Average M17 IC50 Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M17 Leucine Aminopeptidase (PFM17LAP) [AID588679, Type: confirmatory]M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23497510]
View
8
[SID124767876]
Average IC50 QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP) [AID588678, Type: confirmatory]M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220]
View
9
[SID124767876]
Average PFM1AAP IC50 Counterscreen for inhibitors of PFM18AAP: QFRET-based biochemical high throughput dose response assay for inhibitors of the Plasmodium falciparum M1AAP (PFM1AAP) [AID588680, Type: confirmatory]m1-family aminopeptidase [Plasmodium falciparum 3D7] [gi:23615263]
View